Cardiovascular Clinical Studies

This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.

The condition is known to increase the risk of cardiovascular disease and atherosclerosis, a buildup of fats inside the blood vessels that can constrict blood flow to the body’s tissues.

News | Heart Failure

Study Reverses Long-Held Ideas About Relationship Among Diabetes, Fat and Cardiovascular Disease

August 8, 2022 — A major risk factor for diabetes, insulin resistance occurs when the cells of the body do not respond ...

August 08, 2022

The illustration shows a portion of the receptor pGC-A, known as the extracellular domain, which protrudes from cell surfaces in the cardiovascular system. Small molecules bind with the receptor and exert subtle control over blood pressure. The new research offers the first sneak peek at the full-length receptor, a vital step in the development of new drugs to treat hypertension and other afflictions.

News | Hypertension

New Study Explores Cell Receptor Crucial for Cardiovascular Health

August 8, 2022 — Cardiovascular diseases remain a leading cause of death around the world. A primary contributor to ...

August 08, 2022

About one percent of the world population is born with a congenital heart defect, which affects about 40,000 U.S. births each year, but how these particular birth defects come about is largely unknown.

News | Congenital Heart

New Study Provides Insight for How Congenital Heart Defects Manifest

August 2, 2022 — About one percent of the world population is born with a congenital heart defect, which affects about ...

August 02, 2022

RADIANCE II US FDA IDE pivotal trial evaluating the Paradise Ultrasound Renal Denervation (uRDN) System as a treatment for hypertension met its primary efficacy endpoint, demonstrating a statistically significant reduction in daytime ambulatory systolic blood pressure between treatment and a sham procedure measured at two months

News | Hypertension

ReCor Medical and Otsuka Medical Devices Announce Primary Endpoint Met in the RADIANCE II US Pivotal Trial of the Paradise System for the Treatment of Hypertension

July 29, 2022 — ReCor Medical, Inc. and Otsuka Medical Devices Co., Ltd., a fully owned subsidiary of Otsuka Holdings ...

July 29, 2022

a team of cardiovascular experts from the Lankenau Institute for Medical Research (LIMR), part of Main Line Health, used experimental models to discover that a natural product found in plants including safflower holds promise for treating a pair of hereditary sudden cardiac death syndromes

News | Embolization devices

Instylla Announces Positive Results From Preclinical Studies of Embrace Hydrogel Embolic System in Hemorrhage Models

July 28, 2022 — Instylla, Inc., a privately held company developing next-generation liquid embolics for peripheral ...

July 28, 2022

News | Sudden Cardiac Arrest

Main Line Health, Mayo researchers find natural product may prevent sudden cardiac death from rare inherited syndromes

July 28, 2022 — In 2020, a team of cardiovascular experts from the Lankenau Institute for Medical Research (LIMR), part ...

July 28, 2022

The world’s first HIV-positive to HIV-positive heart transplant has been successfully performed at Montefiore Health System in the Bronx.

News | Heart Failure

World’s First HIV-Positive to HIV-Positive Heart Transplant Performed at Montefiore Health System

July 27, 2022 — The world’s first HIV-positive to HIV-positive heart transplant has been successfully performed at Monte ...

July 27, 2022

Dr Aamir Hameed, Lecturer in the Department of Anatomy and Regenerative Medicine and a Principal Investigator with the Tissue Engineering Research Group at RCSI University of Medicine and Health Sciences

News | Heart Failure

New Heart Model to Help Treat Patients with Heart Failure

July 27, 2022 — Researchers from RCSI University of Medicine and Health Sciences have developed a new lab-based model of ...

July 27, 2022

Trial was negatively impacted by the COVID-19 pandemic and did not meet the primary endpoint

News | Pharmaceuticals

dal-GenE Phase 3 Cardiovascular Precision Medicine Outcomes Trial Results Published in European Heart Journal

July 25, 2022 DalCor Pharmaceuticals announced the results of the dal-GenE Phase 3 cardiovascular precision medicine ...

July 25, 2022

that Dhanunjaya DJ Lakkireddy, MD, Medical Director for the Kansas City Heart Rhythm Institute, will initiate a research protocol analyzing the signals acquired by the PURE EP System during Radiofrequency (RF) ablation

News | Cardiovascular Clinical Studies

BioSig Announces Physician-Initiated Research Protocol at The Kansas City Heart Rhythm Institute

July 22, 2022 — BioSig Technologies, Inc. a medical technology company advancing electrophysiology workflow by ...

July 22, 2022

Study intends to demonstrate that ultrasound allows for precise deployment and positive positioning of the MANTA vascular closure device

News | Cardiovascular Ultrasound

Teleflex Announces First Patient Enrollment in MANTA Ultra Study

July 20, 2022 — Teleflex Incorporated, a leading global provider of medical technologies, announced the first patient ...

July 20, 2022

Heart failure development program to focus on Short Term DSR with DSR 2.0

News | Heart Failure

Sequana Medical Completes Enrollment in Phase 2a SAHARA I DSR Study

July 20, 2022 — Sequana Medical NV, a pioneer in the treatment of drug-resistant fluid overload in liver disease and hea ...

July 20, 2022

The Cardiovascular AI Initiative, to be funded by NewYork-Presbyterian, was launched this summer in a virtual meeting featuring approximately 40 representatives from the institutions.

News | Artificial Intelligence

Collaboration Will Advance Cardiac Health Through AI

July 19, 2022 — Employing artificial intelligence to help improve outcomes for people with cardiovascular disease is the ...

July 19, 2022

Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the CE Mark submission for its MAGiC catheter.

News | Catheter

Stereotaxis Announces CE Mark Submission for Robotically Navigated Magic Ablation Catheter

July 18, 2022 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular ...

July 19, 2022

News | Cardiovascular Clinical Studies

scPharmaceuticals Inc. Announces Positive Results from the AT HOME-HF Phase 2 Pilot Study in Heart Failure

July 18, 2022 — scPharmaceuticals Inc., a pharmaceutical company focused on developing and commercializing products ...

July 19, 2022